Financing ·
CollPlant Biotechnologies Ltd. entered into a securities purchase agreement on June 29, 2026, for a private placement…
CLGNCollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd. entered into a securities purchase agreement on June 29, 2026, for a private placement offering of 7,647,061 ordinary shares or pre-funded warrants. The offering includes series A and series B warrants to purchase up to 7,647,061 and 15,294,122 ordinary shares, respectively, at a combined price of $0.34 per share. The company expects gross proceeds of approximately $2.6 million to fund research, development, and strategic business combinations. H.C. Wainwright & Co., LLC is serving as the exclusive placement agent. The offering is expected to close around July 1, 2026. CollPlant Biotechnologies is a biotechnology company focused on plant-based recombinant human collagen.